Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
-
Noosa News19 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General18 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General20 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News21 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate